These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 71453)

  • 1. A simple and inexpensive device for pooling cryoprecipitate.
    Low WT; Gillon R; Jones P
    Lancet; 1977 Sep; 2(8039):641. PubMed ID: 71453
    [No Abstract]   [Full Text] [Related]  

  • 2. DDAVP and cryoprecipitate in mild haemophilia.
    Boulton FE; Smith A
    Lancet; 1979 Sep; 2(8141):535. PubMed ID: 90263
    [No Abstract]   [Full Text] [Related]  

  • 3. Dose requirement for replacement therapy in hemophilia A.
    Allain JP
    Thromb Haemost; 1979 Oct; 42(3):825-31. PubMed ID: 505399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cryoprecipitate, plasmatic fraction rich in antihemophilic globulin (factor VIII). Its use in the treatment of hemophilia].
    Otto-Servais M; Hugues J
    Rev Med Liege; 1969 May; 24(10):401-7. PubMed ID: 5376503
    [No Abstract]   [Full Text] [Related]  

  • 5. A hemophilia home care program utilizing cryoprecipitate.
    Shanberge JN; Kratz NL; Aster RH
    Scand J Haematol Suppl; 1977; 30():85-6. PubMed ID: 267309
    [No Abstract]   [Full Text] [Related]  

  • 6. Disseminated intravascular coagulation and infusion of factor-VIII-inhibitor bypassing activity.
    Stenbjerg S; Jorgensen J
    Lancet; 1977 Feb; 1(8007):360. PubMed ID: 64875
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Use and misuse of cryoprecipitate.
    Hensley MJ
    N Engl J Med; 1975 Jun; 292(24):1299. PubMed ID: 1128599
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of a single administration of cryoprotein and plasma on factor VIII in hemophilia A].
    Vlcková M; Vorlová Z
    Vnitr Lek; 1980 Nov; 26(11):1101-6. PubMed ID: 6789551
    [No Abstract]   [Full Text] [Related]  

  • 9. Cryoprecipitate.
    Armstrong D
    S Afr Med J; 1975 Jul; 49(31):1245-7. PubMed ID: 1154189
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory and clinical evaluation of concentrates for treatment of haemophilia.
    Verstraete M; Vermylen J
    Acta Clin Belg; 1975; 30(5):437-48. PubMed ID: 1221749
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of factor 8 rich cryoproteins in the treatment of hemophilia].
    Vergoz D; Combrisson A; Vialette T; André R
    Transfusion (Paris); 1967; 10(1):3-10. PubMed ID: 6048649
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihaemophilic cryoprecipitate from fresh plasma and its use in haemophilia.
    Brüster H; Glassner K; Riech PC
    Ger Med Mon; 1968 Mar; 13(3):129-33. PubMed ID: 5656869
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Augmenting cryoprecipitate factor VIII activity.
    Nour-Eldin F
    JAMA; 1975 Nov; 234(7):705-6. PubMed ID: 1242448
    [No Abstract]   [Full Text] [Related]  

  • 14. Cryoprecipitate--a new product for the control of bleeding in haemophilic patients.
    Grobbelaar BG; Clyde JH; Seimon L
    S Afr Med J; 1967 Feb; 41(5):91-2. PubMed ID: 6021085
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy for AHF and PTC hemophilia. I.
    Seeler RA
    IMJ Ill Med J; 1970 May; 137(5):518-21. PubMed ID: 4392774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of complications in children with hemophilia A].
    Pliushch OP; Rutberg RA; Pokrovskii PI; Maller AR
    Pediatriia; 1972 Aug; 51(8):46-50. PubMed ID: 5055476
    [No Abstract]   [Full Text] [Related]  

  • 17. Present possibilities of surgical operations in patients with hemophilia A.
    Ziemski JM
    Pol Med J; 1971; 10(5):1279-82. PubMed ID: 5133677
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of factor VIII deficiency on clotting factor utilization in the United States.
    Aledort LM; Goodnight SH; Rao AV; Schwarz J; Whitehurst D; Shapiro SS
    Ric Clin Lab; 1983; 13(1):33-41. PubMed ID: 6407089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction by factor VIII of decreased neutrophil alkaline phosphatase activity in classic haemophilia and von Willebrand's disease.
    Janković GM; Janosević S
    Haematologia (Budap); 1978-1979; 12(1-4):183-8. PubMed ID: 317061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilia management in New Zealand: an Auckland perspective.
    Ockelford PA; Benny AG; Van de Water NS; Berry EW
    N Z Med J; 1989 Apr; 102(866):189-91. PubMed ID: 2496366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.